Clinical Trials · NCT07179939
Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Fudan University
- Enrollment
- 288
- Start date
- Sep 2025
- Locations
- 1 site, China
- Primary endpoint
- PFS